Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|250-254

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 250-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current role of rituximab in systemic lupus erythematosus

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 2, 2015-02 ,pp. : 154-163

John Wiley & Sons Inc

Access to resources Recommend Favorite

Etiopathogenesis of Systemic Lupus Erythematosus

By  

International Archives of Allergy and Immunology, Vol. 123, Iss. 1, 2000-09 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1577-1585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value of HLA‐DR genotype in systemic lupus erythematosus and lupus nephritis: a meta‐analysis

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 1, 2015-01 ,pp. : 17-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologicals for the treatment of systemic lupus erythematosus?

By Gunnarsson Iva   van Vollenhoven Ronald F.  

Annals of Medicine, Vol. 44, Iss. 3, 2012-05 ,pp. : 225-232

Informa Healthcare

Access to resources Recommend Favorite